Get started
Author

Erdem Kolemen

Observed names: E. Kolemen, Erdem Kölemen, Kölemen, Erdem
ORCID: 0000-0003-3708-2479
Observed ORCID: 0000-0003-3708-2479
OpenAlex ID: A5120161579
Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer
2026 · Emel Mutlu Ozkan, Ibrahim Karadağ, et al. · Expert Review of Anticancer Therapy · 3
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025 · Salih Tunbekici, Gokhan Sahin, et al. · International Journal of Cancer · 3
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients
2026 · Muhammet Cengiz, Oktay Bozkurt, et al. · Scientific Reports · 1
PDF
Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study
2026 · Mustafa Ersoy, Umut Kefeli, et al. · Frontiers in Immunology · 1
PDF
Real-World Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients With Advanced Bone Sarcomas: The TOGBONE Study of the Turkish Oncology Group
2026 · Mehmet Cem Fidan, Fatma Keskin Uzundere, et al. · JCO Global Oncology
PDF
Molecular Characterization of ERBB2-Altered Biliary Tract Cancer
2026 · Erdem Kolemen, Gökhan Uygun, et al. · Research Square
PDF
374P Molecular characterization of ERBB2-altered biliary tract cancer
2026 · E. Kolemen, D. Cabuk, et al. · Annals of Oncology
PDF
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study ( TOG / GI ‐ SAFRADJU ‐2501)
2026 · Erman Akkus, Mehmet Kayaalp, et al. · International Journal of Cancer
277P Efficacy of adjuvant trastuzumab with or without pertuzumab after pCR in HER2+ early breast cancer: Preliminary results from the RWE PEARL-HER2 study
2026 · S. Lobo-Martins, N.R. Teixeira Tavares, et al. · ESMO Open
Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab
2026 · Erdem Kolemen, Kazım Uygun, et al. · Discover Oncology
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab
2026 · Gözde Ağdaş, Duygu Bayir, et al. · Scientific Reports
PDF
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)
2026 · Erman Akkus, Mehmet Kayaalp, et al. · JCO Global Oncology
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer
2026 · Muhammet Cengiz, Oktay Bozkurt, et al. · Discover Oncology
Abstract PS3-11-23: Cross-country Treatment Practices after pCR Following Neoadjuvant Trastuzumab (H) and Pertuzumab (P) in HER2+ Early Breast Cancer: Preliminary Results from the PEARL-HER2 Study
2026 · S. Lobo-Martins, G. Gentile, et al. · Clinical Cancer Research
Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer
2026 · Ayse Nuransoy Cengiz, Oktay Bozkurt, et al. · Journal of Clinical Medicine
PDF
Cross-country Treatment Practices after pCR Following Neoadjuvant Trastuzumab (H) and Pertuzumab (P) in HER2+ Early Breast Cancer: Preliminary Results from the PEARL-HER2 Study
2025 · Campôa, E., Agostinetto, E., et al. · Kocaeli Üniversitesi - AVESİS
Karaciğerin Nadir Vasküler Tümörü: Epitelioid Hemanjioendotelyoma Olgu Sunumu
2025 · Uygun, Kazım, Çabuk, Devrim, et al. · Kocaeli Üniversitesi - AVESİS
Metastatik Hepatoselüler Karsinomda Sağ Atriyal Kitle: Nadir Bir Olgu Sunumu
2025 · Uygun, Kazım, Çıtakkul, İlkay, et al. · Kocaeli Üniversitesi - AVESİS
Neoadjuvan İkili Her2 Blokeri Sonrasi Patolojik Tam Yanit (pcr) Elde Edilen Her2-pozitif Erken Evre Meme Kanseri Hastalarinin Klinikopatolojik Özellikleri
2025 · Kölemen, Erdem, Çabuk, Devrim · Kocaeli Üniversitesi - AVESİS
Works count: 19
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type